160 Participants Needed

Electro-Acupuncture for High Blood Pressure

Recruiting at 2 trial locations
ST
SM
Overseen ByShaista Malik, MD, PhD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of California, Irvine
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether electro-acupuncture, which uses small electrical currents through acupuncture needles, can help lower high blood pressure. Participants will receive treatments once a week for eight weeks. The goal is to determine if this method effectively reduces blood pressure in individuals with hypertension. Suitable candidates have mild coronary disease without severe symptoms and currently manage high blood pressure, regardless of medication use. As an unphased trial, this study provides a unique opportunity to explore alternative treatments for managing high blood pressure.

Do I need to stop my current medications for this trial?

The trial does not specify if you need to stop taking your current medications. However, it mentions that patients with high blood pressure can participate with or without antihypertensive medication, suggesting you may not need to stop them.

What prior data suggests that electro-acupuncture is safe for treating high blood pressure?

Research has shown that electro-acupuncture (EA) is generally well-tolerated and might help manage high blood pressure. Studies have found that electrical stimulation on acupuncture points can lower systolic blood pressure (the top number in a blood pressure reading), suggesting EA could be a promising option for people with high blood pressure.

One study supported the idea that EA can be a non-invasive and low-cost way to help control blood pressure. However, the evidence is not yet strong enough to make definite conclusions about its effectiveness, and more research is needed to confirm these findings.

Regarding safety, EA is considered low-risk. The studies reviewed reported no significant serious side effects. As a non-invasive option, EA might be safe for those interested in participating in a clinical trial.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about electro-acupuncture for high blood pressure because it offers a unique, non-pharmaceutical approach to managing the condition. Unlike standard treatments like ACE inhibitors, beta-blockers, or diuretics that rely on chemical interactions in the body, electro-acupuncture uses electrical stimulation at specific points, which may provide a more holistic and potentially fewer side effects. This method taps into the body's own regulatory systems, potentially offering a complementary or alternative option for those who might not respond well to conventional medications. Plus, the treatment is administered once a week, which could be more convenient for people looking for a less frequent dosing schedule.

What evidence suggests that electro-acupuncture might be an effective treatment for high blood pressure?

This trial will compare two different electro-acupuncture treatments for managing high blood pressure. Studies have shown that electro-acupuncture, which uses small electrical currents at specific body points, can help lower blood pressure. One study found that this method reduced systolic pressure but not diastolic pressure. Other research suggests that electro-acupuncture might work by boosting vagal nerve activity, which can lower both blood pressure and heart rate. Another study observed an average blood pressure drop of over 10 mmHg after six months of treatment. These findings suggest that electro-acupuncture could be a promising way to manage high blood pressure.12367

Who Is on the Research Team?

SM

Shaista Malik, MD, PhD, MPH

Principal Investigator

University of California, Irvine

LX

LiFang Xie, PhD, LAc

Principal Investigator

University of California, Irvine

LF

Liang-Wu Fu, MD, PhD

Principal Investigator

University of California, Irvine

Are You a Good Fit for This Trial?

This trial is for adults with high blood pressure, which can be with or without current medication. It's also open to those with mild heart disease but no serious ECG changes. However, it's not for pregnant women, individuals with severe heart issues like ongoing chest pain, peripheral vascular disease, certain ECG abnormalities, orthopedic conditions, skin sensitivities to tapes/dressings, very low blood pressure-related arrhythmias or uncontrolled diabetes and psychological conditions.

Inclusion Criteria

I have mild heart disease with no significant changes in my resting ECG.
I have high blood pressure, with or without medication.

Exclusion Criteria

You have a specific heart condition that shows up on an ECG test.
I have severe heart disease with constant chest pain.
I have heart rhythm problems with low blood pressure.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive electro-acupuncture treatment once a week for 8 weeks to evaluate its effect on blood pressure and other cardiovascular parameters.

8 weeks
8 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Electro-acupuncture control
  • Electro-acupuncture test
Trial Overview The study is testing whether electro-acupuncture (EA) can help lower high blood pressure. Participants will receive either the test EA treatment or a control version of EA. The hypothesis is that EA could have beneficial effects on hypertension based on earlier research in animals and humans.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Group I: Electro-acupuncture testExperimental Treatment2 Interventions
Group II: Electro-acupuncture controlExperimental Treatment2 Interventions

Electro-acupuncture test is already approved in China, United States for the following indications:

🇨🇳
Approved in China as Electro-acupuncture for:
🇺🇸
Approved in United States as Electro-acupuncture for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of California, Irvine

Lead Sponsor

Trials
580
Recruited
4,943,000+

Published Research Related to This Trial

This clinical trial will assess the effectiveness and safety of transcutaneous electrical acupoint stimulation (TEAS) combined with lifestyle modifications in 60 participants with high-normal blood pressure over 12 weeks.
The primary outcome will focus on changes in mean systolic blood pressure, while secondary outcomes will evaluate diastolic blood pressure, progression to hypertension, quality of life, and other health metrics, providing a comprehensive view of TEAS's potential benefits.
Transcutaneous electrical acupoint stimulation for high-normal blood pressure: study protocol for a randomized controlled pilot trial.Wang, Y., Shi, GX., Tian, ZX., et al.[2022]
Acupuncture does not show significant improvement in systolic or diastolic blood pressure compared to sham acupuncture in patients not on antihypertensive medications, based on a review of 4 randomized controlled trials involving 386 participants.
However, acupuncture may significantly lower blood pressure in patients who are already taking antihypertensive medications, suggesting it could be a beneficial adjunct treatment for those individuals.
Acupuncture for essential hypertension: a meta-analysis of randomized sham-controlled clinical trials.Li, DZ., Zhou, Y., Yang, YN., et al.[2022]
A randomized controlled trial involving 60 patients with stage 1 hypertension will assess the effects of transcutaneous electrical acupoint stimulation (TEAS) on blood pressure over 12 weeks, with participants receiving treatment 4 times a week.
The primary outcome will measure changes in mean systolic blood pressure, while secondary outcomes will include diastolic blood pressure, quality of life, body mass index, and physical activity, aiming to provide evidence for the efficacy and safety of TEAS in hypertension management.
Transcutaneous electrical acupoint stimulation for stage 1 hypertension: protocol for a randomized controlled pilot trial.Tian, ZX., Liu, CZ., Qi, YS., et al.[2021]

Citations

Effects of electrical stimulation of acupuncture points on ...It was concluded that Hans electrical stimulation of acupuncture points reduced systolic blood pressure but not the diastolic blood pressure.
Effect of electroacupuncture on blood pressure and quality ...The findings suggest that acupuncture may lower the BP and HR by increasing vagal nerve activity in cases with mild to moderate HTN. When the patient has a ...
Effect of transcutaneous electrical acupoint stimulation at ...Conclusion. TEAS might be a promising adjunctive therapy for hypertension, and the recommended frequency is 10 Hz, which should be confirmed in larger trials.
Long-Lasting Reduction of Blood Pressure by ...Background: Acupuncture at specific acupoints has experimentally been found to reduce chronically elevated blood pressure.
Electroacupuncture for High Blood PressureThe study reported a mean BP reduction of over 10 mmHg after six months of treatment [56]. This result highlights the potential of electro- ...
Transcutaneous electrical acupoint stimulation for high-normal ...Transcutaneous electrical acupoint stimulation (TEAS) might be a non-pharmaceutical therapy option to control BP. This trial aims to determine ...
Efficacy and Safety of Acupuncture for Essential ...Our systematic review indicates there is inadequate high quality evidence that acupuncture therapy is useful in treating hypertension, as the exact effect and ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security